Appendix 2—table 22. “Bone-Rx” Cohort (Region=New York State), Patient Characteristics Pre/Post Match.
| "Bone-Rx" Cohort / Region=New York State Unmatched | "Bone-Rx" Cohort / Region=New York State Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 57,397 | 100.0% | 7,362 | 12.8% | 50,035 | 87.2% | 14,508 | 100.0% | 7,254 | 50.0% | 7,254 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 56 | 0.1% | ≤10 | 0.1% | 50 | 0.1% | <0.001 | 11 | 0.1% | ≤10 | 0.1% | ≤10 | 0.1% | 0.96 |
| 21-40 | 272 | 0.5% | 44 | 0.6% | 228 | 0.5% | 76 | 0.5% | 42 | 0.6% | 34 | 0.5% | ||
| 41-50 | 775 | 1.4% | 120 | 1.6% | 655 | 1.3% | 207 | 1.4% | 107 | 1.5% | 100 | 1.4% | ||
| 51-60 | 7,249 | 12.6% | 885 | 12.0% | 6,364 | 12.7% | 1,744 | 12.0% | 871 | 12.0% | 873 | 12.0% | ||
| 61-70 | 18,433 | 32.1% | 2,297 | 31.2% | 16,136 | 32.2% | 4,540 | 31.3% | 2,264 | 31.2% | 2,276 | 31.4% | ||
| 71-80 | 19,944 | 34.7% | 2,482 | 33.7% | 17,462 | 34.9% | 4,934 | 34.0% | 2,455 | 33.8% | 2,479 | 34.2% | ||
| ≥81 | 10,668 | 18.6% | 1,528 | 20.8% | 9,140 | 18.3% | 2,996 | 20.7% | 1,509 | 20.8% | 1,487 | 20.5% | ||
| Gender | ||||||||||||||
| Female | 52,047 | 90.7% | 6,589 | 89.5% | 45,458 | 90.9% | <.001 | 13,106 | 90.3% | 6,526 | 90.0% | 6,580 | 90.7% | 0.13 |
| Male | 5,350 | 9.3% | 773 | 10.5% | 4,577 | 9.1% | 1,402 | 9.7% | 728 | 10.0% | 674 | 9.3% | ||
| Insurance | ||||||||||||||
| Commercial | 12,309 | 21.4% | 1,894 | 25.7% | 10,415 | 20.8% | <0.001 | 3,706 | 25.5% | 1,850 | 25.5% | 1,856 | 25.6% | 1.00 |
| Dual | 1,750 | 3.0% | 154 | 2.1% | 1,596 | 3.2% | 307 | 2.1% | 153 | 2.1% | 154 | 2.1% | ||
| Medicaid | 10,191 | 17.8% | 1,016 | 13.8% | 9,175 | 18.3% | 1,968 | 13.6% | 987 | 13.6% | 981 | 13.5% | ||
| Medicare | 33,147 | 57.8% | 4,298 | 58.4% | 28,849 | 57.7% | 8,527 | 58.8% | 4,264 | 58.8% | 4,263 | 58.8% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 21,462 | 37.4% | 2,789 | 37.9% | 18,673 | 37.3% | 0.35 | 5,468 | 37.7% | 2,744 | 37.8% | 2,724 | 37.6% | 0.73 |
| Yes | 35,935 | 62.6% | 4,573 | 62.1% | 31,362 | 62.7% | 9,040 | 62.3% | 4,510 | 62.2% | 4,530 | 62.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.06 | 1.84 | 1.81 | 2.56 | 0.95 | 1.68 | <0.001 | 1.69 | 2.35 | 1.69 | 2.36 | 1.69 | 2.35 | 0.98 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.